³ÉÈË¿ìÊÖ

1. Declaration of interests:

Jackie Baillie declared no relevant interests.

2. Decision on taking business in private:

The Committee decided to take items 6, 7 and 8 in private.

3. Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill:

The Committee took evidence on the Bill at Stage 1 from—

Dr Ros Jamieson, Clinical lead for the Complex Mesh National Surgical Service and Mark White,Director of Finance, NHS Greater Glasgow and Clyde ;

Dr Anna Lamont, Interim Medical Director, Procurement Commissioning and Facilities, Roseanne McDonald,Associate Director, Procurement Commissioning and Facilities and Paul Hornby,Head of Strategic Sourcing & Commercial, National Procurement, NHS National Services Scotland .

4. Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Bill:

The Committee took evidence on the Bill at Stage 1 from—

Humza Yousaf, Cabinet Secretary for Health and Social Care, Greig Chalmers,Head of Chief Medical Officer’s Policy Division, Terry O'Kelly,Senior Medical Adviser, David Bishop,Mesh Team Leader and Ailsa Garland,Solicitor, Scottish Government .

5. Subordinate legislation:

The Committee considered the following negative instruments—

6. Evidence Session

The Committee considered the evidence it heard earlier under agenda items 3 and 4.

7. Health and Wellbeing of Children and Young People:

The Committee agreed its approach to the inquiry.

8. Perinatal Mental Health:

The Committee agreed its approach to the inquiry.